Together Pharma Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.56	8.44	3.59	5.3	5.1	5.76
Cash & Short-Term Investments	9.56	8.44	3.59	5.3	5.1	5.76
Cash Growth	26.12%	135.08%	-32.17%	3.94%	-11.51%	406.42%
Accounts Receivable	23.15	16.99	12.63	8.35	0.91	1.34
Other Receivables	1.68	2.55	0.44	0.09	0.22	0.77
Receivables	24.83	19.54	13.06	8.44	1.13	2.11
Inventory	54.36	56.38	55.26	44.59	46.53	36.8
Prepaid Expenses	-	0.14	0.37	0.99	0.41	0.3
Other Current Assets	-	-	0.45	-	34.08	0.47
Total Current Assets	88.75	84.5	72.74	59.31	87.24	45.43
Property, Plant & Equipment	34.53	35.47	35.44	36.59	34.8	35.05
Long-Term Investments	-	-	-	0.1	-	-
Goodwill	16.18	16.18	16.18	16.18	16.18	16.18
Other Intangible Assets	9.69	8.54	12	15.43	18.43	21.91
Other Long-Term Assets	2.46	2.37	2.2	2.2	2	6.66
Total Assets	151.61	147.05	138.55	129.79	158.65	125.23
Accounts Payable	26.82	21.36	13.76	9.36	6.21	7.35
Accrued Expenses	-	4.55	6.82	5.12	2.92	2.97
Short-Term Debt	30.22	27.48	11.89	15.59	6.21	0.42
Current Portion of Long-Term Debt	3.99	14	17.35	6.09	39.69	4.49
Current Portion of Leases	1.44	1.48	1.56	1.4	0.62	0.02
Current Unearned Revenue	-	-	-	-	0.3	-
Other Current Liabilities	17.66	9.95	10.84	9.77	10.24	6.14
Total Current Liabilities	80.13	78.82	62.22	47.32	66.19	21.39
Long-Term Debt	3.65	9.73	13.31	25.97	29.77	43.46
Long-Term Leases	10.56	10.87	10.69	11.02	9.08	8.85
Pension & Post-Retirement Benefits	-	-	-	-	0.04	0.04
Long-Term Deferred Tax Liabilities	4.79	3.45	3.99	-	-	-
Other Long-Term Liabilities	2.91	5.97	50.88	42.45	27.86	36.77
Total Liabilities	102.04	108.84	141.1	126.77	132.94	110.51
Common Stock	251.76	239.76	194.62	197.39	183.96	152.14
Retained Earnings	-212.16	-213.14	-211.97	-207.65	-174.13	-160.35
Comprehensive Income & Other	7.18	6.7	9.56	9.83	10.79	16.5
Total Common Equity	46.78	33.32	-7.79	-0.43	20.63	8.29
Minority Interest	2.79	4.89	5.24	3.45	5.08	6.42
Shareholders' Equity	49.57	38.21	-2.55	3.02	25.71	14.71
Total Liabilities & Equity	151.61	147.05	138.55	129.79	158.65	125.23
Total Debt	49.87	63.57	54.8	60.08	85.37	57.25
Net Cash (Debt)	-40.31	-55.12	-51.21	-54.78	-80.27	-51.49
Net Cash Per Share	-2.88	-4.44	-5.83	-6.72	-11.72	-8.93
Filing Date Shares Outstanding	14.24	13.81	8.79	8.79	7.53	6.39
Total Common Shares Outstanding	14.24	13.81	8.79	8.79	7.43	5.6
Working Capital	8.62	5.68	10.51	11.99	21.05	24.04
Book Value Per Share	3.28	2.41	-0.89	-0.05	2.78	1.48
Tangible Book Value	20.91	8.61	-35.97	-32.03	-13.98	-29.8
Tangible Book Value Per Share	1.47	0.62	-4.09	-3.65	-1.88	-5.33
Machinery	-	19.4	18.16	17.33	17	15.32
Leasehold Improvements	-	15.41	14.53	14.22	13.11	13.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.